Genoox partners with Thermo Fisher Scientific to automate cytogenetic research data interpretation and reporting with AI

PALO ALTO, Calif.–(TYPE OF BUSINESS)– Thermo Fisher Scientific has upgraded its flagship Applied Biosystems Chromosome Analysis Suite (ChAS) software in partnership with Genoox, a community-driven genomic data company. ChAS users will be able to access Genoox’s cloud-based AI platform, Franklin, by implementing CytoScan’s Automated Interpretation and Reporting (AIR) solution, making cytogenetic research data analysis simpler.

By automating interpretation and reporting, ChAS with Franklin provides an intuitive and flexible workflow for immediate access to consistent, reproducible cytogenetic analysis results. While manual interpretation can take hours, ChAS users can now obtain accurate results in seconds.

“We developed ChAS software with input from leading cytogeneticists and continue to work with our customers to make data simpler and more intuitive,” said Chad Carter, vice president and general manager, microarray genetic solutions, Thermo Fisher Scientific. “By partnering with Genoox, we can make data interpretation even easier so our customers can focus on their research.”

“We are excited to partner with Thermo Fisher Scientific, a leader in cytogenetics,” said Amir Trabelsi, CEO and co-founder of Genoox. “We created Franklin to advance genomic medicine by giving users access to real-world, real-time genomic data. The merger of ChAS with Franklin furthers this mission, and we look forward to opening up the platform to ChAS users.

About Genox

Genoox leverages the power of its community to deliver actionable insights from the largest real-time, real-life genomic database serving professionals at the point of care. Genoox’s cloud-based AI platform, Franklin, connects clinicians, genetic counselors, and healthcare organizations while enabling platform users to make impactful discoveries using state-of-the-art genomic tools and applications. Genoox is used by more than 2,100 healthcare organizations, hospitals and medical facilities in 46 markets worldwide. Visit our website for more information: www.genoox.com.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is a world leader in science services with annual revenues of approximately $40 billion. Our mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical problems, increasing productivity in their laboratories, improving patient health through diagnostics, or developing and manufacturing life-changing therapies, we are here to support them. Our global team delivers an unmatched combination of innovative technology, shopping convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Source

Also Read :  Juniper Research: AI-Enabled Financial Fraud Detection Spend to Exceed $10 Billion by 2027, as Businesses Seek to Combat Increasingly Sophisticated Fraudulent Attacks

Leave a Reply

Your email address will not be published.

Related Articles

Back to top button